Summary: Activity of serum/plasma -N-acetylhexosaminidase (EC 3.2.1.52) was determined by means of a continuous spectrophotometric method using 3,3'-dichlorophenylsulphonphthaleinyl-N-acetyl--Z)-glucosaniinide as substrate, with very satisfactory results. Incubation of an undiluted aliquot (1 ml) of samples at 52 °C for 8 hours with an adjusted pH 5.5-6.0 provoked only the inactivation of isoenzyme A, thus allowing the evaluation of -JVacetylhexosaminidase isoenzyme composition. In 25 serum samples from control subjects and pregnant women, a good correlation between the percentage of isoenzyme B obtained by this procedure and the fluorimetric assay of O'Brien et al. (New Engl J Med 1970; 273:15-20) was found (r = 0.983, Syx = 1.51), with no statistically significant difference between the means (43.2 vs 42.8%). In 84 healthy adult subjects, an average value of 30.3% for the proportion of isoenzyme B was obtained, with an interval of 25.4-35.0%, in agreement with results reported by other authors.
Introduction
The lysosomal enzyme -W-acetylhexosaminidase (EC 3.2.1.52) 1 ) consists of two major isoenzymes, denoted A and B. -Af-Acetylhexosaminidase A is a heterodimer composed of α and β subunits, whereas -JV-acetylhexosaminidase Β is a homodimer solely comprised of β subunits (1, 2) . The so called intermediate forms ( -Afacetylhexosaminidase I), including P-form which increase in serum during pregnancy, are post-translational modifications.
Until a few years ago, the almost exclusive clinical application of -N-acetylhexosaminidase assay was the biochemical diagnosis of gangliosidoses GM2 (Sandhojfs and Toy-Sachs diseases) and the detection of carriers. However, more recent studies have revealed a developing interest in other physiopathological situations (3 -11) . For the determination of the β-ΛΓ-acetylhexosaminidase isoenzymes, various electrophoretic, Chromatographie and immunochemical techniques have been proposed, although the traditional heat inactivation assays are still used more often due to their simplicity (1) . These methods are based on the varying stability of isoenzymes A and B with increases in temperature. Under conditions where the pH is 4.4, isoenzyme B is relatively thermostable for a temperature of 50-55 °C, whereas isoenzyme A is rapidly inactivated. In order to ! ) Enzyme -W-acetymexosaminidase: -JV-acetyl-£>-hexosaminide ΛΓ-acetylhexosamino hydrolase EC 3.2.1.52 perform heat treatment of the samples a large dilution is done with a citrate buffer, which requires a high analytical sensitivity of the assay for the measurement of enzyme activity. This is carried out using substrates derived from 4-methylumbelliferone that become fluorescent chromophore when hydrolyzed by the enzyme. A large number of synthetic substrates have been manufactured which allow spectrophotometric determination of -Af-acetylhexosaminidase activity (7, 12) ; however, their lower analytical sensitivity makes it difficult to adapt them to this particular type of differential heat inactivation assay of β-ΛΓ-acetylhexosaminidase isoenzymes.
In the present study a heat inactivation procedure at 52 °C was developed that permitted the determination of β-,/V-acetylhexosaminidase isoenzymes in serum/plasma using a continuous spectrophotometric method adapted to a centrifugal analyzer.
Materials and Methods
Catalytic activities of -JV-acetylhexosaminidase were measured using 3,3'-dichlorophenylsulphonphthaleinyl-W-acetyl--£>-glucosaminide as substrate (13) of the reagent solution, 8.2 ml of distilled water was added to each bottle containing lyophilized synthetic substrate and buffer. Under these conditions, the final concentration of the substrate in the reaction mixture was the same as that specified in the instructions for the manual procedure. The calculation factor was established regarding the enzyme activity of Precimat ß-NAG® and Precinorm ß-NAG® standards (Boehringer Mannheim GmbH, Mannheim, Germany) whose assigned values are calculated on the basis of the molar absorptivity of the released chlorophenolred under standardized conditions (14) .
It must be pointed out that the enzyme activity found therefore for the Stand NAG® control from Shionogi and Co., Ltd., was on average 68% (n = 18) of the assigned value by the manufacturer. This fact could be due to the assigned enzyme activity for this control material occurring so that the continuous method using the 3,3 '-dichlorophenylsulphonphthaleinyl-JV-acetyl-ß-Z)-glucosaminide substrate gave equivalent activity to that of the discontinuous method using the substrate m-cresolsulphonphthaleinyl-7V-acetyl-ß-D-glucosaminide (15) . However, the results obtained by various authors have demonstrated that the use of the substrate »z-cresolsulphonphthalernyl-Af-acetyl-ß-D-glucosaminide gives significantly higher enzyme activity than when 3,3'-dichlorophenylsulphonphrnaleinyl-W-acetyl-ß-D-glucosaminide is used (16) (17) (18) . Consequently, if the Stand NAG® control is used then the programmed calculation factor in the analyzer should be 863.
A pH-meter for biological fluids Radiometer model ABL-300 (Radiometer, Copenhagen, Denmark) was used for determining the pH of serum samples.
Statistical analysis of the data was carried out using the SPSS package. To check for normality, skewness and kurtosis coefficients or the Shapiro-Wilk test were used, depending on the size of the sample. The significance of difference between mean values was evaluated by the Wilcoxon sign range test for matching data and by the Mann-Whitney U test for unpaired data. Normally distributed data were analyzed statistically by means of Pearson's correlation coefficient, otherwise Spearman's coefficient was used. Linear regression analysis was performed using the Passing-Bablok method. A p-value less than 0.05 was considered to be significant.
Results
When the 3,3'-dichlorophenylsulphonphthaleinyl-7V-acetyl-ß-Z)-glucosaminide method was used to determine the activity of ß-W-acetylnexosaminidase in urine, excluding the slight enzyme-inhibiting effect of urea, it did not appear that other endogenous metabolites, such as urobilinogen, bilirubin, haemoglobin or glucose could seriously interfere (17, 19) . However, it was necessary to investigate the possible effect of elevated concentrations of albumin and globulins so that this substrate could be used for determining enzyme activity in serum or plasma. To do this, different quantities of bovine albumin (Ektachem Solution Bovine Serum Albumin®, Johnson and Johnson Clinical Diagnostics Inc., Rochester, USA) were added to different Precimat ß-NAG® control vials belonging to the same lot. The results obtained are presented in figure 1 , showing that bovine albumin produces an inhibitory effect on ß-JV-acetylhexosaminidase activity. Human albumin produced an analogous inhibition, since the addition of fresh serum samples from different patients, whose ß-JV-acetylhexosaminidase activity had been previously determined, provided equivalent results to those that would be expected Consequently, in order to determine ß-JV-acetylhexosaminidase in serum/plasma and in pleural or peritoneal fluids, the enzyme activities obtained should be recalculated by means of the correction factors relevant to the albumin concentration shown in calculation factor of 700 (587 X 1.192), corresponding to an albumin concentration of 45 g/1, may be used in the programmation of the analyzer for routine determination of serum ß-N-acetylhexosaminidase activity. The inaccuracy resulting from this approximation would be a maximum of 2.5% for serum albumin concentrations included in the reference interval. In 35 serum samples from patients with different liver diseases and with an average albumin concentration of 36 g/1 (interval = 18-51 g/1), the activities thus obtained gave an excellent correlation against the individually corrected values for the albumin concentration (r = 0.997, S yx = 0.45), with no statistically significant difference between the means (11.4U/lvs ll.OU/1).
The precision obtained in the determination of serum ß-W-acetylnexosaminidase must be considered as very good, as shown in table 2, where the enzyme activity remained unaltered for at least 60 days in samples frozen at -20 °C. In all cases, the coefficient of variation was less than the medically accepted value according to the criteria of the College of American Pathologists (20) .
An excellent correlation was achieved between the enzyme activities in serum obtained by means of the continuous method using 3,3'-dichlorophenylsulphonphthaleinyl-W-acetyl-ß-ß-glucosaminide (CPR-NAG) and the discontinuous method using 2-methoxy-4-(2'-nitrovi- The possible effect of different anticoagulants on ß-Afacetylhexosaminidase activity was investigated by adding 4 pools of sera to Vacutainer® tubes (Becton-Dickinson Vacutainer Systems, Rutherford, USA) to half the volume of blood drawn into the tubes. No significant change in enzyme activity was observed due to the lithium heparinate, K 3 EDTA, sodium citrate or citratedextrose (data not shown).
The parallel analysis of ß-7V-acetylhexosaminidase activities in serum and plasma (blood collected with K 3 EDTA as anticoagulant) gave the results shown in figure 2 , where values in serum were significantly higher than in plasma (p < 0.001). This fact was not due to a simple dilution effect produced by the anticoagulant, as this was taken into account when calculating the activities in plasma. The difference between the means was superior to the medically acceptable error according to the criteria of the College of American Pathologists (20) . A highly significant correlation between the difference of serum/plasma activity and the platelet count in blood was found, as shown in figure 3 . This difference in activity also shows a statistically significant correlation with the packed platelet volume and the leukocyte count in blood (tab. 3). Nevertheless, since the platelet and leukocyte counts showed a significant correlation between themselves (r = 0.500, p < 0.001), the partial correlation between the difference of serum/ plasma activity and the leukocyte count, keeping the platelet count constant, did not reach statistical significance (r = 0.180, NS).
In 187 sera from healthy adult subjects of both sexes, we found a mean activity of 7.3 U/l (SEM = 0.09; interval = 5.1-10.2 U/l) and in 114 plasma samples a mean Since the heat inactivation of the enzymes is strongly influenced by the protein concentration of the medium (23), for the selective heat inactivation of isoenzyme A in samples of undiluted native serum, a careful optimization of the experimental conditions had to be carried out. A study published in 1993 by Isaksson et al. (24) was used as a starting point. In this work it was pointed out that after the incubation of 5 serum samples at 37 °C for 15 hours, more than 80% of isoenzyme B remained and less than 10% of isoenzyme A, whose catalytic activity and antigenic properties were destroyed together.
The incubation of 11 native serum samples at 37 °C, in aliquots of 1 ml in closed tubes, led to an inactivation of ß-7V-acetylhexosaminidase which was stabilized after 12 hours, as shown in figure 4 . Once separated from the clot, the serum suffered an increase in pH due to a loss of CO 2 depending on the temperature and the empty space remaining in the tube above the samples (25) . The rapid inactivation at room temperature of the serum acid phosphatase was attributed to this increase in pH (25) . ß-7V-Acetylhexosaminidase in serum would appear to be more stable, since its remains fairly active under these conditions for a period of at least 24 hours (26, 27), a fact which we have confirmed. However, at 37 °C, in samples that reach pH =» 8.5, alkalinization could play an important role in the inactivation of ß-TV-acetylhexosaminidase. As shown in figure 4 , acidification with citric acid of the serum samples to pH « 6.0 prevents the inactivation of ß-A/-acetylhexosaminidase during incubation at 37 °C.
Subsequently, a systematic study of the pH effect of serum samples on the heat inactivation of ß-N-acetylhexosaminidase was carried out, although in order to optimize the operative methodology, incubation was performed at 52 °C. This temperature was established as a compromise value in view of the temperature interval (50-55 °C) recommended by various authors for the heat inactivation of isoenzyme A in diluted serum samples with a buffer (1, 26, 31, 36 In all cases, a significant correlation for p < 0.001 was found. 5) . Consequently, the pH effect of the samples was systematically investigated in a sera pool taken from healthy control subjects and from another pool of pregnant women adjusted to different pH values and subjected to an 8 hours incubation period at 52 °C. The results obtained are shown in figure 6 . It can be seen that the maximum residual activity for both sera pools was obtained for the interval of pH 5.5-6.0. Above and below these limit values a rapid fall in enzyme activity can be observed, mainly for more acidic pH values, in which a plainly visible white protein precipitate was noted. Incubation at 52 °C and pH «= 5.8 of ß-N-acetylhexosaminidase A and P purified human placental isoenzymes, supplemented with bovine serum albumin 50 g/1, lead to the results shown in figure 7 . The residual activity after 8 hours of incubation was always more than 95% for ß-N-acetylhexosaminidase P, whilst for isoenzyme A it was about 10%. An electrophoretic study in cellulose acetate showed that this commercial purified isoenzyme A presents an additional fraction with mobility similar to isoenzyme B and which represents about 10% of the total activity. This would explain the residual activity found in the heat inactivation assay. On the contrary, the purified ß-./V-acetylhexosaminidase P showed a single homogeneous electrophoretic band with similar migration to that of isoenzyme B.
The only difference between serum ß-7V-acetylhexosaminidase P and isoenzyme B seems to be that P-form contains more sialic acid (28) . Threehundred of a neuraminidase (EC 3.2.1.18) solution from Vibrio cholerae 1 kU/1 (Boehringer Mannheim GmbH), free of -W-acetylhexosaminidase activity, were added to 1 ml of different pH adjusted sera (pH «5.8) from healthy control subjects and pregnant women (n = 8) and, after being incubated at room temperature for 7-24 hours, the respective assays of heat inactivation at 52 °C was carried out. The desialylation of ß-N-acetylhexosaminidase by the neuraminidase did not significantly modify the residual activity values obtained (data not shown), which suggests that P-form and isoenzyme B show analogous thermostability. The heat inactivation assay of isoenzyme A was carried out in 10 aliquots of 1 ml from a sera pool adjusted to pH «= 5.8, giving a mean residual activity of 53.7%, with a SD = 0.79 and therefore a CV = 1.47%.
In 25 serum samples taken from control subjects and pregnant women a mean value of 43.2% for the proportion of isoenzyme B was obtained, by means of the heat inactivation procedure described, and of 42.8% by the fluorimetric assay of O 'Brien et al. (26) , showing a good correlation between the values: 4MU-NAG = 0.96 X CPR-NAG + 1.30 (r = 0.983, S y . x = 1.51, p < 0.001).
Therefore, the heat treatment of native serum samples adjusted to pH 5.5-6.0 and incubated at 52 °C for 8 hours permits the differential inactivation of isoenzymes A and B. The addition of 11 of acetic acid at 20% to 1 ml of serum, or of a tablet containing 4 mg of citric acid (Prostatic Acid Stabilizer Tablets®, Sigma Chemical Co.) to 1.5 ml of serum, provided the samples with a pH « 5.8, which is very suitable for the inactivation of isoenzyme A under the conditions described. In the case of women in their 5th-9th month of pregnancy, a suitable pH was obtained by adding 10 of acetic acid at 20% to 1 ml of serum. This is possibly due to the haemodilution which occurs over this period. The addition of acetic or citric acid to different serum samples as described (n = 20) led to about 3% loss of enzyme activity.
In a control group of 84 healthy adult subjects, isoenzyme A and activity in serum was determined using the heat inactivation procedure described, leading to an average value for the proportion of isoenzyme of 30.3% (SEM = 0.28%) with a reference interval of 25.4-35.0%.
Discussion
The above results demonstrate that ß-7V-acetylhexosaminidase activity in serum or plasma can be determined rapidly and precisely using 3,3'-dichlorophenylsulphonphthalemyl-Af-acetyl-ß-Z)-glucosammide as substrate. The albumin seemed to be able to bind with this substrate, subsequently forming the ternary complex enzyme-inhibitor-substrate and hindering the formation of the chromophore, which would be in agreement with the type of non-competitive inhibition found. When using 2-methoxy-4-(2'-nitrovinyl)-phenyl-A^-acetyl-ß-£)-glucosaminide as substrate, no significant inhibition of the -^-acetylhexosaminidase was noted, even using albumin concentrations of 70 g/1. The different molecular structures of both substrates could explain why the 3,3'-dichlorophenylsulphonphthaleinyl-N-acetyl-ß-Z)-glucosaminide, whose molecule includes three benzene rings, is bound to the albumin, while the 2-methoxy-4-(2'-nitrovinyl)-phenyl-JV-acetyl-ß-Z)-glucosaminide, whose less bulky molecule with only one benzene ring, would not create a bond with this protein. In any case, this inhibition does not seem to be a serious drawback for the use of 3,3'-dichlorophenylsulphonphthaleinyl-7V-acetyl-ß-Z)-glucosaminide to determine the ß-7V-acetylhexosaminidase in biological fluids with high concentrations of albumin such as serum or plasma.
As far as the difference in activity of the ß-N-acetylhexosaminidase in serum and plasma is concerned, and even the possible effects of anticoagulants, the bibliographic data are not conclusive. O'Brien et al. (27) andNatowicz et al. (29) do not find significant differences between enzyme activity in serum and plasma. On the other hand, Suzuki et al. (30) and O'Brien (31) point out that ß-N-acetylhexosaminidase would be inhibited by heparin, which could explain the lower activity obtained in plasma collected with this anticoagulant. However, according to Lombardo et al. (32) , heparin, citrate, oxalate or EDTA would not affect per se ß-JV-acetylhexosaminidase activity, as our results have also shown. Likewise, these authors find significantly higher ß-7V-acetylhexosaminidase activity in serum than in plasma, and suggest that the release of enzyme from the platelets could occur during coagulation. Recently, Emiliani et al. (33) have demonstrated that stimulation with thrombin provokes a release by platelets of ß-Af-acetylhexosaminidase and other glycohydrolases.
We also found greater enzyme activity in serum than in plasma, there being a highly significant correlation between the difference in serum/plasma activity and the platelet count ( fig. 3) , which clearly supports the hypothesis suggested by Lombardo et al. (32) . On the other hand, the partial correlation study which was carried out seems to indicate that no significant release of leukocyte ß-jV-acetylhexosaminidase to serum takes place during coagulation.
The procedure developed for the heat inactivation of isoenzyme A at 52 °C for 8 hours in specimens of serum or plasma adjusted to pH 5.5-6.0, allows for the use of spectrophotometric methods in the evaluation of the ß-TV-acetylhexosaminidase isoenzyme composition. The addition of acetic or citric acid to the serum samples, as indicated in the results, produces a slight inactivation of ß-JV-acetylhexosaminidase (approx. 3%) which must be taken into account. Acetate shows a clear inhibitory effect on ß-JV-acetylhexosaminidase (l, 34), however, the low concentrations reached in the reaction mixture under experimental conditions used here must be considered.
The study of heat inactivation using the procedure described, carried out with the purified human placental ß-JV-acetylhexosaminidase P, showed a residual activity of more than 95% in every case. Regarding the residual activity found in purified human placental isoenzyme A (approx. 10%), it may be explained by contamination of this preparation by isoenzyme B discovered electrophoretically. The conversion of isoenzyme A to isoenzyme B, by reordering the subunits in the purified tissue forms, is well documented in literature (1, 35) .
The substrate 3-methylumbelliferyl-7V-acetyl-ß-Z)-glucosaminide is commonly used in laboratories interested in the study of ß-W-acetylhexosaminidase isoenzymes, as it offers suitable sensitivity due to the chromophore released by the enzymatic action being fluorogenic. However, fluorimetric methods require dedicated equipment, and the low solubility of 4-methylumbelliferyl-./Vacetyl-ß-Z)-glucosaminide and its instability in solution, as well as problems in interlaboratory standardization (7, 12) should also be considered as possible drawbacks. It is in this aspect that spectrophotometric methods could offer certain advantages, and could be used in the evaluation of the ß-N-acetylhexosaminidase isoenzyme composition in serum or plasma using the procedure described here for the heat inactivation of isoenzyme A. The values obtained for the proportion of isoenzymes A and B in 84 healthy adult subjects of both sexes are analogous to those given by other authors using different analytical methods (5, 24, (35) (36) (37) .
